Alliance Pharma (LON:APH) Announces Quarterly Earnings Results

Alliance Pharma (LON:APH) released its quarterly earnings data on Tuesday. The company reported GBX 4.32 ($0.06) EPS for the quarter, Digital Look Earnings reports. Alliance Pharma had a negative net margin of 18.34% and a negative return on equity of 15.24%.

Alliance Pharma Trading Up 0.2 %

Shares of APH opened at GBX 64.30 ($0.82) on Wednesday. Alliance Pharma has a twelve month low of GBX 24.55 ($0.31) and a twelve month high of GBX 66.20 ($0.85). The company has a current ratio of 2.93, a quick ratio of 1.42 and a debt-to-equity ratio of 46.27. The company’s fifty day simple moving average is GBX 62.70 and its 200-day simple moving average is GBX 53.03. The company has a market cap of £348.15 million, a P/E ratio of -10.36, a P/E/G ratio of 1.04 and a beta of 0.67.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank cut shares of Alliance Pharma to a “hold” rating and dropped their price objective for the stock from GBX 7,000 ($89.45) to GBX 6,250 ($79.86) in a research note on Wednesday, January 29th.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.